[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2933984B1 - D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses - Google Patents

D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Info

Publication number
FR2933984B1
FR2933984B1 FR0804017A FR0804017A FR2933984B1 FR 2933984 B1 FR2933984 B1 FR 2933984B1 FR 0804017 A FR0804017 A FR 0804017A FR 0804017 A FR0804017 A FR 0804017A FR 2933984 B1 FR2933984 B1 FR 2933984B1
Authority
FR
France
Prior art keywords
atheromous
muramyldipeptide
plaques
treatment
derivative compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0804017A
Other languages
English (en)
Other versions
FR2933984A1 (fr
Inventor
Matthieu Pesant
Jean Louis Connat
Luc Rochette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Bourgogne
Original Assignee
Universite de Bourgogne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Bourgogne filed Critical Universite de Bourgogne
Priority to FR0804017A priority Critical patent/FR2933984B1/fr
Priority to PCT/FR2009/000863 priority patent/WO2010007250A1/fr
Publication of FR2933984A1 publication Critical patent/FR2933984A1/fr
Application granted granted Critical
Publication of FR2933984B1 publication Critical patent/FR2933984B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR0804017A 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses Expired - Fee Related FR2933984B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0804017A FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
PCT/FR2009/000863 WO2010007250A1 (fr) 2008-07-15 2009-07-13 D, d muramyldipeptides, composes derives et utilisation pour le traitement des plaques atheromaieuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804017A FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Publications (2)

Publication Number Publication Date
FR2933984A1 FR2933984A1 (fr) 2010-01-22
FR2933984B1 true FR2933984B1 (fr) 2013-01-04

Family

ID=40380727

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0804017A Expired - Fee Related FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Country Status (2)

Country Link
FR (1) FR2933984B1 (fr)
WO (1) WO2010007250A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862107D1 (en) * 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
GR78246B (fr) * 1981-01-23 1984-09-26 Ciba Geigy Ag
GB9413935D0 (en) * 1994-07-11 1994-08-31 Peptech Uk Ltd Use of maramyl peptide compounds
WO1998046251A1 (fr) * 1997-04-11 1998-10-22 Oleg Vitalievich Kaljuzhin Regulateur immunologique, composition pharmaceutique possedant une activite antitumorale et additif alimentaire

Also Published As

Publication number Publication date
FR2933984A1 (fr) 2010-01-22
WO2010007250A1 (fr) 2010-01-21

Similar Documents

Publication Publication Date Title
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
IL213070A0 (en) Methods for the treatment of infections and tumors
BRPI0917575A2 (pt) métodos de tratamento de talassemia
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
EP2361089A4 (fr) Compositions et procédés pour le traitement d une fonction altérée de l' -synucléine
BRPI0914294A2 (pt) aparelho de tratamento de cápsulas
PL2353403T3 (pl) Zastosowanie 1-(2,4-dihydroksy-fenylo)-3-(3-hydroksy-4-metoksy-fenylo)-propan-1-onu
DK2175851T3 (da) Biofilmbehandling
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
FR2920671B1 (fr) Implant textile, notamment pour la refection des hernies
FI20085693A0 (fi) Biosignaalin prosessointi
IL210290A0 (en) Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
ZA201005282B (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
BRPI0914139A2 (pt) composições pediátricas para o tratamento de esclerose múltipla
IL207247A0 (en) Use of ranolazine for the treatment of cardiovascular disease
IL211189A0 (en) Compounds for the treatment of peripheral neuropathies
EP2271328A4 (fr) Compositions antiseptiques pour le traitement d infections
ITBO20080072A1 (it) Apparato per il trattamento di materiali di rifiuto
IT1403597B1 (it) Procedimento per il trattamento di materiali tessili
ZA201101821B (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin deases
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
IT1390968B1 (it) Frazione glicolipidica di cianobatterio per il trattamento delle affezioni del cavo orale
BRPI0919816A2 (pt) uso compostos benzoxazólicos no tratamento de malária

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160331